跳至主要内容
临床试验/CTRI/2024/07/070853
CTRI/2024/07/070853尚未招募2 期

Evaluation of effectiveness of individualized homoeopathic medicine on quality of life in patients on hemo-dialysis in end stage kidney disease: a placebo control study.

Dr Anil Vishnu Paradkar1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2024年8月1日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
Outcome will be assessed in terms of:

研究概览

简要总结

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed cases of End Stage Kidney Disease on Hemodialysisfrom both the sex of all socio-economic status Patients of End Stage Kidney Disease on Hemodialysis with comorbidities of Diabetes Mellites, Hypertension, Cardiovascular Diseases.
  • Patients of End Stage Kidney Disease on Hemodialysis for at least 3Months.

排除标准

  • End Stage Kidney Disease Patients taking treatment for any other systemic disorder except morbidities leading to End Stage Kidney Disease.

结局指标

主要结局

Outcome will be assessed in terms of:

时间窗: 1 year

1.Improved

时间窗: 1 year

2.Not Improved

时间窗: 1 year

次要结局

  • IMPROVEMENT IN QUALITY OF LIFE IN PATIENT ON BASIS OF KDQOL(1 YEAR)

研究者

发起方
Dr Anil Vishnu Paradkar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Anil Vishnu Paradkar

YMT homoeopathic medical college and PG institute

研究点 (1)

Loading locations...

相似试验